Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 4
2000 1
2001 3
2002 2
2003 2
2004 4
2005 4
2006 8
2007 3
2008 2
2009 6
2010 8
2011 6
2012 4
2013 5
2014 6
2015 5
2016 9
2017 4
2018 4
2019 7
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 26767706

85 results
Results by year
Filters applied: . Clear all
Page 1
The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study).
Vaneckova M, Herman M, Smith MP, Mechl M, Maravilla KR, Weichet J, Spampinato MV, Žižka J, Wippold FJ 2nd, Baima JJ, Babbel R, Bültmann E, Huang RY, Buhk JH, Bonafé A, Colosimo C, Lui S, Kirchin MA, Shen N, Pirovano G, Spinazzi A. Vaneckova M, et al. AJNR Am J Neuroradiol. 2015 Sep;36(9):1589-98. doi: 10.3174/ajnr.A4468. Epub 2015 Jul 16. AJNR Am J Neuroradiol. 2015. PMID: 26185325 Free PMC article. Clinical Trial.
Breast lesion detection and characterization with contrast-enhanced magnetic resonance imaging: Prospective randomized intraindividual comparison of gadoterate meglumine (0.15 mmol/kg) and gadobenate dimeglumine (0.075 mmol/kg) at 3T.
Clauser P, Helbich TH, Kapetas P, Pinker K, Bernathova M, Woitek R, Kaneider A, Baltzer PAT. Clauser P, et al. J Magn Reson Imaging. 2019 Apr;49(4):1157-1165. doi: 10.1002/jmri.26335. Epub 2018 Dec 15. J Magn Reson Imaging. 2019. PMID: 30552829 Free PMC article. Clinical Trial.
Cerebral neoplastic enhancing lesions: multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0M) and gadoterate meglumine (0.5M) at 0.1 mmol Gd/kg body weight in a clinical setting.
Anzalone N, Scarabino T, Venturi C, Cristaudo C, Tartaro A, Scotti G, Zimatore D, Floris R, Carriero A, Longo M, Cirillo M, Cova MA, Gatti S, Voth M, Colosimo C. Anzalone N, et al. Eur J Radiol. 2013 Jan;82(1):139-45. doi: 10.1016/j.ejrad.2011.07.005. Epub 2011 Sep 3. Eur J Radiol. 2013. PMID: 21890295 Clinical Trial.
Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 versus 3 T.
Attenberger UI, Runge VM, Morelli JN, Williams J, Jackson CB, Michaely HJ. Attenberger UI, et al. J Magn Reson Imaging. 2010 Mar;31(3):549-55. doi: 10.1002/jmri.22089. J Magn Reson Imaging. 2010. PMID: 20187196
85 results